Answers are grounded in this paper and cite their sources.
In the hen, the preoptic area, medial basal hypothalamus, and anterior lobe of the pituitary showed a greater uptake of [3H]estradiol-17 beta (E2) in vivo than other tissues. This uptake was decreased when unlabeled diethylstilbestrol was injected together with the [3H]E2 or when unlabeled E2 was injected before the [3H]E2 injection. A specific estrogen binding component having properties of a receptor was found in vitro in both soluble and insoluble fractions of these tissues in a hypotonic buffer solution. The administration of E2 in vivo caused a marked decrease in the estrogen receptor binding in the soluble fraction with a concomitant increase in binding in the insoluble fraction; as a result, total binding (sum of the bindings in soluble and insoluble fraction) did not change.
No takes yet. Share an insight, caveat, or question.
Kawashima et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: